Member Info for Kiwi_

A lot of buys going through

Wow, shes a rising lads and leddetts!

Bladey, are Miton facing redemptions?

Fill or kill to buy already

langtro, how chunky was chunky? ;)

I hope you all had a great weekend, I think STX still has room for positive movement after attaining FDA approval on Friday due to less than 5% of shares in issue available in free-float. Market look's like it has a ways to go yet along with a possible up front payment of £100 Million this Q/H

96.06% SHares in issue tightly held, that is eye watering when we consider none are likely to sell anytime soon.

W. Health LP 56,012,475 48.1%
Maru AG 12,532,918 10.8%
Carl Sterritt, MBA 10,163,496 8.73%
Richard Ian Griffiths 9,074,260 7.79%
JPMorgan Asset Management (UK) Ltd. 6,240,425 5.36%
Christian Schweiger 5,646,654 4.85%
USS Investment Management Ltd. 5,099,452 4.38%
Hargreave Hale Ltd. 4,115,000 3.53%
SpreadEx Ltd. 1,488,746 1.28%
Richard Crispin Morgan Jones 1,448,990 1.24%

hxxps://www.marketscreener.com/SHIELD-THERAPEUTICS-PLC-26786173/company/

96.06% SHares in issue tightly held, that is eye watering when we consider none are likely to sell anytime soon.

W. Health LP 56,012,475 48.1%
Maru AG 12,532,918 10.8%
Carl Sterritt, MBA 10,163,496 8.73%
Richard Ian Griffiths 9,074,260 7.79%
JPMorgan Asset Management (UK) Ltd. 6,240,425 5.36%
Christian Schweiger 5,646,654 4.85%
USS Investment Management Ltd. 5,099,452 4.38%
Hargreave Hale Ltd. 4,115,000 3.53%
SpreadEx Ltd. 1,488,746 1.28%
Richard Crispin Morgan Jones 1,448,990 1.24%

https://www.marketscreener.com/SHIELD-THERAPEUTICS-PLC-26786173/company/

Hi everyone, great to see the rise here. Has anyone got broker targets other than that from Peel Hunt? I see they have 143p of which is far to conservative

Buys coming in at 7% premium to the Ask

Fill or kill only with all that weekend press before Monday

zoro9791, are you sure both those trades are yours?

Techs: Break 185p and we are 208p bound

https://www.barchart.com/stocks/quotes/STX.LN/cheat-sheet

It will get there mate, look at all the times it has been fill or kill then trades are ater reported. The most recent being 125K shares bought in three tranches. Try buying now, says it all mate, just wait until the yanks start waking up

£500m+ Annual Revenue Targeted for Feraccru and Feraccru is happening NOW folks!

Here is the link:

https://www.telegraph.co.uk/markets-hub/share/S1957/STX/ShieldTherapeutics

Shield Therapeutics STX(London Stock Exchange)
Shield Therapeutics plc is a de-risked commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs. The Company's clear purpose is to help its patients become people again, by enabling them to enjoy the things that make the difference in their everyday lives. The Group has a marketed product, Feraccru®, for the treatment of iron deficiency in adults which has exclusive IP rights until the mid-2030s. Feraccru is commercialised in the European Union by Norgine BV and the US Food and Drug Administration (FDA) is currently considering a New Drug Application (NDA), with a PDUFA (Prescription Drug User Fee Act) date of 27 July 2019.

A lot of large buys being delayed in reporting if you check the times and spread when they occurred

Absolubtely mate, bring China and Japan markets on board along with partnerships I wouldn't like to even guess how high this could go

FDA approval significantly increases the chance of China and Japan approval

I suspect this will go crazy as the US markets open up, hardly anything priced in here